Publications by authors named "Elizabeth Lendermon"

Claim this Profile
I
Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials.
Derek E Byers, Ramsey Hachem, Chadi A Hage, Rajat Walia, Hilary Goldberg, Elizabeth Lendermon

Transplant Direct· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical Trials.
Derek E Byers, Ramsey Hachem, Chadi A Hage, Rajat Walia, Hilary Goldberg, Elizabeth Lendermon

Transplantation· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Immunocompromise in Solid Organ Transplantation.
Elizabeth A Lendermon, Chadi A Hage

Clin Chest Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of bilateral orthotopic lung transplantation in the management of acute severe drug-induced interstitial lung disease: A case report.
Derek K Afflu, Brittany A Cody, Elizabeth Lendermon, Pablo G Sanchez

JHLT Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.
Ghady Haidar, Jana L Jacobs, Kailey Hughes Kramer, Asma Naqvi, Amy Heaps, Elizabeth Lendermon

Clin Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Lung Transplant Go (LTGO): A randomized controlled trial evaluating the efficacy of a telerehabilitation behavioral exercise intervention to improve physical activity, physical function, and blood pressure control after lung transplantation.
Melissa L Vendetti, Seol Ju Esther Moon, Christopher C Imes, Andrea Hergenroeder, Frank Sciurba, Elizabeth Lendermon

Contemp Clin Trials Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent.
Iulia Popescu, Mark E Snyder, Carlo J Iasella, Stefanie J Hannan, Ritchie Koshy, Elizabeth A Lendermon

Am J Respir Crit Care Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
Masashi Furukawa, Ernest G Chan, John P Ryan, Eric J Hyzny, Lauren M Sacha, Elizabeth A Lendermon

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors of bronchial dehiscence after primary lung transplantation.
Masashi Furukawa, Ernest G Chan, Matthew R Morrell, John P Ryan, Ryan M Rivosecchi, Elizabeth A Lendermon

J Card Surg· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of tissue resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation.
Mark E Snyder, Kaveh Moghbeli, Anna Bondonese, Andrew Craig, Iulia Popescu, Elizabeth Lendermon

J Exp Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans.
Mark E Snyder, Anna Bondonese, Andrew Craig, Iulia Popescu, Matthew R Morrell, Elizabeth Lendermon

Am J Transplant· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.
Carlo J Iasella, Aki Hoji, Iulia Popescu, Jianxin Wei, Mark E Snyder, Elizabeth A Lendermon

Am J Transplant· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival.
Carlo J Iasella, Spencer A Winters, Abigail Kois, Jaehee Cho, Stefanie J Hannan, Elizabeth A Lendermon

Am J Transplant· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.
Iulia Popescu, Hannah Mannem, Spencer A Winters, Aki Hoji, Fernanda Silveira, Elizabeth A Lendermon

Am J Respir Crit Care Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Foxp3+ T lymphocytes: immune regulators within the lung allograft.
Elizabeth A Lendermon, John F McDyer

J Clin Invest· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after lung transplantation for patients with occupational lung diseases.
Kyla D Joubert, J Awori Hayanga, Diane C Strollo, Elizabeth A Lendermon, Samuel A Yousem

Clin Transplant· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier.
Christopher R Ensor, Kimberly C Goehring, Carlo J Iasella, Cody A Moore, Elizabeth A Lendermon

Clin Transplant· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors.
Carlo J Iasella, Ryan J Winstead, Cody A Moore, Bruce A Johnson, Ayelet T Feinberg, Elizabeth A Lendermon

Transplantation· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation.
Elizabeth A Lendermon, Tiffany A Coon, Joseph S Bednash, Nathaniel M Weathington, John F McDyer

Respir Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperexpansion of Functional Viral-Specific CD8+ T Cells in Lymphopenia-Associated MCMV Pneumonitis.
Pali D Shah, Qiong Zhong, Elizabeth A Lendermon, Matthew R Pipeling, John F McDyer

Viral Immunol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.
Elizabeth A Lendermon, Jeffrey M Dodd-o, Tiffany A Coon, Hannah L Miller, Sudipto Ganguly

Am J Respir Cell Mol Biol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells.
Khalequz Zaman, Silvia Carraro, Joseph Doherty, Edward M Henderson, Elizabeth Lendermon

Mol Pharmacol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis